Fennec Pharmaceuticals Inc (FENC) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $8.61
• Market Cap: $304.31M
• EPS: $-0.26
• 52-Week High: $9.92
• 52-Week Low: $4.68

Market Sentiment

Fennec Pharmaceuticals Inc currently has a Bullish sentiment score of 0.19.

About Fennec Pharmaceuticals Inc

Fennec Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Research Triangle Park, North Carolina, dedicated to developing pioneering treatments for cancer, especially among pediatric patients. The company's lead product candidate, Pedmark, targets chemotherapy-induced ototoxicity in children, representing a vital innovation in oncology care. With a strong focus on enhancing patient quality of life, Fennec is well-positioned to make significant advancements in the oncology la...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Fennec Pharmaceuticals Inc and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does FENC pay dividends?

Fennec Pharmaceuticals Inc (FENC) does not currently pay a regular dividend.

What is FENC's market cap?

Fennec Pharmaceuticals Inc (FENC) has a market capitalization of $304.31M with a current stock price of $8.61.